Overview

Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus

Status:
Completed
Trial end date:
2012-09-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to determine whether insulin glulisine is more effective in postprandial glycemic control than insulin aspart after the H-GI meal in children with type 1 diabetes (T1DM) treated with insulin pump (CSII).
Phase:
Phase 4
Details
Lead Sponsor:
Medical University of Warsaw
Treatments:
Insulin
Insulin Aspart
Insulin degludec, insulin aspart drug combination
Insulin glulisine
Insulin, Globin Zinc
Insulin, Long-Acting